Adlai Nortye Group Statistics
NASDAQ: ANLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
14.05-0.41 (-2.84%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Adlai Nortye Group by the numbers
Adlai Nortye Group has a market capitalization of $904.8 million based on 58.73M shares outstanding. With trailing EPS of $-0.66, Adlai Nortye Group is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.3% below its 50-day average and 34.1% above its 200-day average.
Average daily trading volume is 179.55K shares, or about $2.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ANL valuation vs. peer median
| Metric | ANL | Peer median | Difference |
|---|---|---|---|
| Market cap | $904.79M | $906.52M | -0% |
| Avg. volume | 179.55K | 753.51K | -76% |
Peer median across 8 companies: ANRO, MLTX, KURA, SPTX, RIGL, CYRX, ALMS, JBIO.
Valuation
- Market cap
- $904.79M
- EPS (TTM)
- $-0.66
- Shares outstanding
- 58.73M
Price and trading
- Previous close
- 14.46
- Open
- 14.20
- Day range
- 14.03 – 15.04
- 52-week range
- 0.879 – 17.25
- 52-week change
- +712.14%
- Beta
- —
- Volume
- 95.06K
- Average volume
- 179.55K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 8, 2025
Additional statistics
- Market Cap
- 904.79M
- Forward Pe
- -47.74
- Eps
- -0.66
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 17.25
- Week52 Low
- 0.88
- Avg Volume
- 179.55K
- Shares Outstanding
- 58.73M
- Ma50
- 14.38
- Ma200
- 10.48
- Earnings Date
- Aug 8, 2025
- Pct From52w High
- -18.55%
- Pct From52w Low
- 1498.41%